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Introduction
The rewarding and motor effects produced by endocannabinoids and THC are mediated primarily through the CB1R (Ferre et al., 2010; Monory et al., 2007) . CB1Rs and the endocannabinoids 2-AG and anandamide are expressed within the dopamine-enriched basal ganglia networks controlling these behaviors, thus suggesting that the motivational and motor effects of endocannabinoids are ascribed at least in part to modulation of dopamine transmission (Di Marzo et al., 2000; Matyas et al., 2008) . The rewarding effects produced by addictive substances as well as food and other natural reinforcers result largely from their capacity to enhance mesolimbic dopamine transmission (Berridge, 2007; Ikemoto, 2010) . The key mesolimbic reward pathway originates from dopamine neurons in the VTA that project extensively to the shell compartment of the Acb, but mesocortical dopamine neurons that are also located in the VTA project to the PFC (Lapish et al., 2007; Van den Heuvel and Pasterkamp, 2008) . In contrast, the nigrostriatal dopamine output from the SN to the dorsal striatum is a potent modulator of motor functions (Smith and Villalba, 2008) that are also highly influenced by cannabinoids (Walsh et al., 2010) . The involvement of cannabinoids in modulation of dopamine transmission within these neural networks is supported by the abnormalities in reward and motor function in CB1R (−/−) mice (Steiner et al., 1999) . In this review, we summarize the evidence indicating that presynaptic and receptor interactive mechanisms enable cannabinoids to fine-tune the activity of mesocorticolimbic and nigrostriatal dopamine neurons (Fig. 1) .
Microscopic analysis of the endocannabinoid and dopamine systems
Electron microscopic and confocal immunolabeling have contributed significantly to our understanding of the mesocorticolimbic and nigrostriatal dopamine systems and their affiliation with endocannabinoids principally acting through the CB1R. These methods are complementary and also confirm and extend many of the pre-and post-synaptic findings regarding the functionally relevant sites gleaned from electrophysiological methods.
Electron microscopic imaging
The combined use of electron microscopic immunolabeling and electrophysiological methods led to the initial contention that Abbreviations: 2-AG, 2-arachidonoylglycerol; Acb, nucleus accumbens; CB1R, cannabinoid CB1 receptor; CCK, cholecystokinin; D1R, dopamine D1 receptor; D2R, dopamine D2 receptor; DAT, dopamine transporter; GABA, gamma-Aminobutyric acid; NAPE-PLD, N-acylphospatidylethanolamine-hydrolizing phospholipase D; NET, norepinephrine transporter; PFC, prefrontal cortex; SN, substantia nigra; SNpc, substantia nigra pars compacta; SNpr, substantia nigra pars reticulata; TH, tyrosine hydroxylase; THC, delta9-tetrahydrocanabinoid; VTA, ventral tegmental area.
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